| __timestamp | PTC Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 242549000 |
| Thursday, January 1, 2015 | 121816000 | 245098000 |
| Friday, January 1, 2016 | 117633000 | 147600000 |
| Sunday, January 1, 2017 | 117456000 | 264600000 |
| Monday, January 1, 2018 | 171984000 | 357900000 |
| Tuesday, January 1, 2019 | 257452000 | 1182600000 |
| Wednesday, January 1, 2020 | 477643000 | 357700000 |
| Friday, January 1, 2021 | 540684000 | 540100000 |
| Saturday, January 1, 2022 | 651496000 | 322900000 |
| Sunday, January 1, 2023 | 666563000 | 408000000 |
Data in motion
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, United Therapeutics Corporation and PTC Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, PTC Therapeutics increased its R&D spending by over 730%, peaking in 2023 with an investment of approximately $667 million. Meanwhile, United Therapeutics saw a more modest growth of around 68% in the same period, with a notable spike in 2019 when their R&D expenses reached nearly $1.18 billion. This strategic allocation of resources underscores the companies' commitment to pioneering new treatments and therapies. As the biotech landscape evolves, these investments highlight the critical role of R&D in maintaining a competitive edge and delivering innovative solutions to patients worldwide.
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Comparing Innovation Spending: United Therapeutics Corporation and Neurocrine Biosciences, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
Research and Development Expenses Breakdown: United Therapeutics Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc